Bryan Cox

Chief Tech/Sci/R&D Officer at TRISALUS LIFE SCIENCES, INC.

Net worth: 528 294 $ as of 2026-08-30

64 year

Health Technology

Consumer Services

Profile

Bryan F.
Cox is currently Chief Executive Officer & Director at Nephraegis Therapeutics, Inc. since 2018 and Chief Research Officer at TriSalus Life Sciences, Inc. since 2020.
Formerly, Dr. Cox was Director-Integrative Pharmacology at Abbott Laboratories from 1996 to 2013.
Education includes a doctorate from the University of Iowa and an undergraduate degree from The University of North Carolina at Chapel Hill.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
TRISALUS LIFE SCIENCES, INC. 0.17%	2026-03-19	106,726 ( 0.17% )	528 294 $	2026-08-30

Bryan Cox active positions

Companies	Position	Start
TRISALUS LIFE SCIENCES, INC.	Chief Tech/Sci/R&D Officer	2020-05-31
Nephraegis Therapeutics, Inc. Nephraegis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops kidney therapies	Chief Executive Officer	2018-10-31

All active positions of Bryan Cox

Former positions of Bryan Cox

Companies	Position	End
ABBOTT LABORATORIES	Corporate Officer/Principal	2012-12-31

See the detail of Bryan Cox's experience

Training of Bryan Cox

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Bryan Cox's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
Abbott Laboratories Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products	Health Technology
University of Iowa University of Iowa Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
The University of North Carolina at Chapel Hill The University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Nephraegis Therapeutics, Inc. Nephraegis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops kidney therapies	Health Technology
TriSalus Life Sciences, Inc. TriSalus Life Sciences, Inc. Medical SpecialtiesHealth Technology Engages in research, development and sales of innovative drug delivery technology & immune-oncology therapeutics	Health Technology